SBFM - Kapitalisasi pasar sunshinebiopharma.com

Logo grafis Sunshine Biopharma, Inc. (SBFM)

The stock price trend for Sunshine Biopharma (SBFM) on the GURU.Markets platform reflects the dynamics of an asset whose revenue is based on bringing breast cancer and antiviral drugs to market. The current indicator is 0.00. Sunshine Biopharma (SBFM) combines the production of generic drugs with scientific research to combat resistant tumors. Meanwhile, amid unstable revenues and a need for investment, management is adjusting its medical plans.

SBFM Sunshine Biopharma Inc.: Biji pasar ing interval 04.07.2022 - 22.10.2026

Rincian metrik lan analitis perusahaan Sunshine Biopharma Inc. (SBFM)

Pambiji fundamental perusahaan:Sunshine Biopharma, Inc. SBFM
Sampel barang Sunshine Biopharma

The market capitalization of Sunshine Biopharma (SBFM) is calculated as the product of the current share price and the total number of outstanding securities. This aggregator measures the total value of the business, reflecting market confidence in the issuer's assets. For Sunshine Biopharma, this metric depends directly on the efficiency of climate regulation compliance during the delivery of oncology drugs. Stable logistics chains minimize the risks of medication degradation. By analyzing the company's public capitalization chart, an investor can assess the fundamental stability of the business.

Pesaing Sunshine Biopharma (SBFM)

Kapitalisasi pasar ONC (BeiGene)|Halozyme Therapeutics, Inc. - Nilai pasar|RevMed - Kapitalisasi pasar|Biji pasar AAPG|CG Oncology, Inc. (CGON) - Nilai pasar|Biji pasar urogen.com|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|HURA: Nilai pasar|Biji pasar TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar WHWK (Aadi Bioscience)|TCRX - Biji pasar|CSBR: Biji pasar|XBIT - Kapitalisasi pasar|cel-sci.com (CVM) - Nilai pasar|OS Therapies Inc. - Nilai pasar|RADX (Radiopharm Theranostics) - Kapitalisasi pasar|Nilai pasar Artiva ARTV|Nilai pasar Adlai Nortye Ltd. (ANL)|Kapitalisasi pasar verupharma.com|Tempest Therapeutics, Inc. - Biji pasar|Kapitalisasi pasar Xilio Therapeutics Inc XLO|RENB - Nilai pasar|MURA (Mural Oncology plc) - Kapitalisasi pasar|kairospharma.com (KAPA) - Nilai pasar|OKUR - Kapitalisasi pasar|GDTC (CytoMed Therapeutics Ltd) - Kapitalisasi pasar|CRIS: Nilai pasar|Kapitalisasi pasar APLM|Kapitalisasi pasar Tharimmune Corporation|Nilai pasar Advanced Biomed ADVB|GNPX: Kapitalisasi pasar|Calidi Bio - Kapitalisasi pasar|Nilai pasar Xenetic Biosciences|SLRX (Salarius) - Biji pasar|Kitov Pharma - Nilai pasar|AONC (American Oncology Network Inc) - Kapitalisasi pasar|Nilai pasar BGNE|Kapitalisasi pasar CKPT|Kapitalisasi pasar Elevation Oncology Inc.|Nilai pasar iCAD ICAD|Ikena Oncology Inc. (IKNA) - Nilai pasar|NTBL - Nilai pasar|Biji pasar VIRX|MOR: Kapitalisasi pasar|NAYA Biosciences Inc - Nilai pasar|AAPGV (Ascentage Pharma Group Ltd) - Kapitalisasi pasar